PHARMACYTE BIOTECH

pharmacyte-biotech-logo

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®. This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech’s treatment for pancreatic... cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This “targeted chemotherapy” has proven remarkably effective in past clinical trials. In addition, PharmaCyte Biotech is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop “green” approaches to fighting deadly cancers, such as those of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.

#SimilarOrganizations #People #Financial #Event #Website #More

PHARMACYTE BIOTECH

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Medical Medical Device

Founded:
1996-01-01

Address:
Laguna Hills, California, United States

Country:
United States

Website Url:
http://www.pharmacytebiotech.com

Total Employee:
11+

Status:
Active

Contact:
(917)595-2850

Email Addresses:
[email protected]

Total Funding:
87.14 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator Amazon California Region


Similar Organizations

ansun-biopharma-logo

Ansun BioPharma

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

northwest-biotherapeutics-logo

Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

senseonics-logo

Senseonics

Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.


Current Advisors List

kenneth-waggoner_image

Kenneth Waggoner Chairman of the Board of Directors @ PharmaCyte Biotech
Board_member

gerald-crabtree_image

Gerald Crabtree Member of the Board of Directors @ PharmaCyte Biotech
Board_member

manuel-hidalgo_image

Manuel Hidalgo Member of the Medical & Scientific Advisory Board @ PharmaCyte Biotech
Advisor

matthias-lohr_image

Matthias Lohr Chairman of the Medical & Scientific Advisory Board @ PharmaCyte Biotech
Advisor

mark-rabe_image

Mark Rabe Member of the Medical & Scientific Advisory Board @ PharmaCyte Biotech
Advisor

thomas-liquard_image

Thomas Liquard Member of the Board of Directors @ PharmaCyte Biotech
Board_member
2015-04-27

brian-salmons_image

Brian Salmons Member of the Medical & Scientific Advisory Board @ PharmaCyte Biotech
Advisor

hans-peter-hammes_image

Hans-Peter Hammes Member of the Medical & Scientific Advisory Board @ PharmaCyte Biotech
Advisor

Current Employees Featured

kenneth-waggoner_image

Kenneth Waggoner
Kenneth Waggoner Chief Executive Officer, President and General Counsel @ PharmaCyte Biotech
Chief Executive Officer, President and General Counsel
2013-09-01

gerald-crabtree_image

Gerald Crabtree
Gerald Crabtree Chief Operating Officer @ PharmaCyte Biotech
Chief Operating Officer

walter-gunzburg_image

Walter Gunzburg
Walter Gunzburg CSO @ PharmaCyte Biotech
CSO

matthias-lohr_image

Matthias Lohr
Matthias Lohr Consultant @ PharmaCyte Biotech
Consultant

eva-maria-brandtner_image

Eva Maria Brandtner
Eva Maria Brandtner Director of Diabetes Program Development @ PharmaCyte Biotech
Director of Diabetes Program Development

not_available_image

Jose Iglesias
Jose Iglesias Consulting Chief Medical Officer @ PharmaCyte Biotech
Consulting Chief Medical Officer

Stock Details


Company's stock symbol is NASDAQ:PMCB

Acquisitions List

Date Company Article Price
2011-07-21 PharmaCyte Biotech PharmaCyte Biotech acquired by PharmaCyte Biotech N/A

Official Site Inspections

http://www.pharmacytebiotech.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 3.33.251.168
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "PharmaCyte Biotech"

PharmaCyte Biotech, Inc. (PMCB)

May 21, 2024 PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: …See details»

PharmaCyte Biotech, Inc. | PharmaCyte Biotech is a …

PharmaCyte Biotech Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: [email protected] Latest News. PharmaCyte Biotech Board of Directors …See details»

PharmaCyte Biotech - Crunchbase Company Profile & Funding

PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to …See details»

PharmaCyteBiotech

PharmaCyteBiotechSee details»

PharmaCyte Biotech, Inc. | Company

Aug 15, 2022 PharmaCyte Biotech Inc. 3960 Howard Hughes Parkway, Suite 500 Las Vegas, Nevada 89169 Office Number: 917.595.2850 Facsimile Number: 917.595.2851 Email: [email …See details»

PharmaCyte Biotech, Inc. (PMCB) - Yahoo Finance

See the company profile for PharmaCyte Biotech, Inc. (PMCB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

PharmaCyte Biotech - LinkedIn

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary …See details»

PharmaCyte Biotech Company Profile - Office Locations ... - Craft

Oct 4, 2024 PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. It uses its …See details»

PharmaCyte Biotech, Inc. - AnnualReports.com

PharmaCyte Biotech, Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) Older/Archived Annual Reports. 2022 Annual Report View Annual Report Download. 2021 …See details»

PharmaCyte Biotech, Inc. - Prism MarketView

Jan 2, 2024 PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway Suite 500 Las Vegas, NV 89169 United States. 917 595 2850; https://pharmacyte.com; [email protected]; PharmaCyte Biotech is a clinical stage biotechnology …See details»

PharmaCyte Biotech, Inc. | Las Vegas NV - Facebook

PharmaCyte Biotech, Inc., Las Vegas, Nevada. 1,537 likes · 1 was here. PharmaCyte Biotech (NASDAQ: PMCB) is a clinical stage biotechnology company focused on developing targeted treatments for cancer...See details»

PharmaCyte Biotech Announces Launch of New Corporate Website

PharmaCyte Biotech’s new website is the latest step in a transformation process to brand PharmaCyte Biotech as solely a biotechnology firm. With the recent name and ticker symbol …See details»

PharmaCyte Biotech, Inc. (PMCB) - Yahoo Finance

Find the latest PharmaCyte Biotech, Inc. (PMCB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

PharmaCyte Biotech - Overview, News & Similar companies

May 20, 2024 Who is PharmaCyte Biotech. PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and …See details»

PharmaCyte Biotech, Inc. (PMCB) - Stock Analysis

2 days ago About PMCB. PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are …See details»

PharmaCyte Biotech - Contacts, Employees, Board Members

Organization. PharmaCyte Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Number of Board Member and Advisor Profiles 8. Contacts 1. …See details»

PharmaCyte Biotech - Funding, Financials, Valuation & Investors

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer. Search Crunchbase. ... How much funding …See details»

PharmaCyte Biotech: A Balanced Look (NASDAQ:PMCB)

Jan 12, 2015 PharmaCyte Biotech (OTCQB:PMCB) (Formally Nuvilex) is a quite curious company. The company is engaged, along with its subsidiaries, in the biotech field and the …See details»

PharmaCyte Biotech, Inc. | PharmaCyte Biotech Releases More …

Sep 21, 2021 PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests. 21 SEP 21 ... The study, which was performed by a third-party Contract …See details»

PharmaCyte forced to think outside the box as CEO departs amid …

Oct 7, 2022 Pharmacyte Biotech FDA Chutes and Ladders clinical hold Long-time PharmaCyte CEO Kenneth Waggoner has departed the biotech, leaving amid a cost freeze on all programs …See details»

linkstock.net © 2022. All rights reserved